-

AM Best Affirms Credit Ratings of Central States Indemnity Co. of Omaha and CSI Life Insurance Company

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings of “aa-” (Superior) of Central States Indemnity Co. of Omaha (CSI), and its subsidiary, CSI Life Insurance Company (CSI Life). The outlook of these Credit Ratings (ratings) is stable. Both companies are domiciled in Omaha, NE.

The ratings reflect CSI’s and CSI Life’s balance sheet strength, which AM Best assesses as strongest, as well as their adequate operating performance, limited business profile and appropriate enterprise risk management.

Additionally, CSI and CSI Life benefit from their very conservative underwriting leverage, above average liquidity position and the implicit support from their ultimate parent, Berkshire Hathaway Inc. (Berkshire) [NYSE: BRK A and BRK B] via investment management services, capital and risk management. CSI is a specialty insurance company, which provides credit card credit insurance and has fronting agreements with multiple insurers, in the aerospace and agricultural lines of business in several states.

These positive rating factors are offset by CSI’s elevated common stock leverage, which may bring volatility to the company’s surplus. CSI currently writes more non-credit insurance premiums on a gross basis compared with its long-standing credit insurance business. Most of CSI’s gross premiums written are related to long-term fronting arrangements.

CSI Life’s rating affirmations reflect its synergies with CSI. The ratings also reflect CSI Life’s strongest level of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), and the explicit support provided by CSI, as well as the implicit support from Berkshire. Offsetting rating factors include CSI Life’s limited business profile and lack of product diversification.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Guilherme Monteiro Simoes, CFA
Senior Financial Analyst
+1 908 882 2317
guy.simoes@ambest.com

Gregory Dickerson
Director
+1 908 882 1737
gregory.dickerson@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

AM Best


Release Versions
Hashtags

Contacts

Guilherme Monteiro Simoes, CFA
Senior Financial Analyst
+1 908 882 2317
guy.simoes@ambest.com

Gregory Dickerson
Director
+1 908 882 1737
gregory.dickerson@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

Social Media Profiles
More News From AM Best

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...

AM Best Downgrades Credit Ratings of A-CAP Group Members; Maintains Under Review With Negative Implications Status

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating (FSR) to C+ (Marginal) from B (Fair) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “b-” (Marginal) from “bb+” (Fair) of Atlantic Coast Life Insurance Company (Charleston, SC) and Sentinel Security Life Insurance Company (Salt Lake City, UT). Both companies are collectively referred to as A-CAP Group. Concurrently, AM Best has maintained the under review with negative implications status for these Cre...

AM Best to Deliver Presentation at 2026 ACLI Annual Conference

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will speak at the American Council of Life Insurers (ACLI) Annual Conference, which will take place Oct. 14-16, 2026, in Orlando, FL. Kenneth Frino, managing director, and Erik Miller, senior director, both of AM Best, will deliver a presentation, titled, “Life and Annuity Segment in Transition,” during which they will focus on operating results across the life/annuity segment, as well as investment strategies, rating activity trends and AM Best’s segment...
Back to Newsroom